Bayer AG, the German drugmaker preparing to split off its plastics unit, is still considering ways to expand its animal-health division after missing out on earlier takeovers, Chief Executive Officer Marijn Dekkers said.
Analysts have said that proceeds from Bayer’s planned divestiture of the MaterialScience plastics business could be used to help buy a company that would add products for pets and farm animals, such as Zoetis Inc., the market leader and formerly a part of Pfizer Inc.
“We’ve always looked at different animal-health opportunities that have come and gone,” Dekkers said in an interview at Bayer’s headquarters in Leverkusen. “It’s a very attractive business for us,” and “we’ve always looked with interest in it. It hasn’t happened with us yet.”
Help employers find you! Check out all the jobs and post your resume.
